The stock of 60 Degrees Pharmaceuticals Inc (SXTP) has seen a -11.62% decrease in the past week, with a -27.34% drop in the past month, and a -27.06% decrease in the past quarter. The volatility ratio for the week is 10.24%, and the volatility levels for the past 30 days are at 9.37% for SXTP. The simple moving average for the past 20 days is -16.36% for SXTP’s stock, with a -73.81% simple moving average for the past 200 days.
Is It Worth Investing in 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Right Now?
Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SXTP is 8.73M and currently, short sellers hold a 1.50% of that float. On May 06, 2024, SXTP’s average trading volume was 262.30K shares.
SXTP) stock’s latest price update
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP)’s stock price has gone decline by -9.48 in comparison to its previous close of 0.23, however, the company has experienced a -11.62% decrease in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-19 that 60 Degrees Pharma Presents Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting
SXTP Trading at -20.66% from the 50-Day Moving Average
After a stumble in the market that brought SXTP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.57% of loss for the given period.
Volatility was left at 9.37%, however, over the last 30 days, the volatility rate increased by 10.24%, as shares sank -23.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.81% lower at present.
During the last 5 trading sessions, SXTP fell by -11.62%, which changed the moving average for the period of 200-days by -93.64% in comparison to the 20-day moving average, which settled at $0.2478. In addition, 60 Degrees Pharmaceuticals Inc saw -79.41% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SXTP starting from XU CHERYL, who purchase 200,000 shares at the price of $0.38 back on Jan 31 ’24. After this action, XU CHERYL now owns 424,934 shares of 60 Degrees Pharmaceuticals Inc, valued at $75,000 using the latest closing price.
DOW GEOFFREY S, the President and CEO of 60 Degrees Pharmaceuticals Inc, purchase 25,974 shares at $0.38 during a trade that took place back on Jan 31 ’24, which means that DOW GEOFFREY S is holding 703,599 shares at $9,740 based on the most recent closing price.
Stock Fundamentals for SXTP
Current profitability levels for the company are sitting at:
- -30.21 for the present operating margin
- -1.78 for the gross margin
The net margin for 60 Degrees Pharmaceuticals Inc stands at -21.76. The total capital return value is set at -1.04.
Based on 60 Degrees Pharmaceuticals Inc (SXTP), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -26.31. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -2.25.
Currently, EBITDA for the company is -5.05 million with net debt to EBITDA at -7.7. When we switch over and look at the enterprise to sales, we see a ratio of 2.7. The receivables turnover for the company is 0.74for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.55.
Conclusion
To wrap up, the performance of 60 Degrees Pharmaceuticals Inc (SXTP) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
